Á lódáil...
Dipeptidyl peptidase-4 and kidney fibrosis in diabetes
Diabetic nephropathy (DN) is the most common cause of end-stage kidney disease worldwide and is associated with increased morbidity and mortality in patients with both type 1 and type 2 diabetes. Recent evidence revealed that dipeptidyl peptidase-4 (DPP-4) inhibitors may exhibit a protective effect...
Na minha lista:
| Foilsithe in: | Fibrogenesis Tissue Repair |
|---|---|
| Main Authors: | , , |
| Formáid: | Artigo |
| Teanga: | Inglês |
| Foilsithe: |
BioMed Central
2016
|
| Ábhair: | |
| Rochtain Ar Líne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4752740/ https://ncbi.nlm.nih.gov/pubmed/26877767 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13069-016-0038-0 |
| Clibeanna: |
Cuir Clib Leis
Gan Chlibeanna, Bí ar an gcéad duine leis an taifead seo a chlibeáil!
|